SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-15-002149
Filing Date
2015-04-23
Accepted
2015-04-23 13:18:18
Documents
7
Period of Report
2015-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 4437
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 737
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 737
4 GRAPHIC exhibit99-1x1x1.jpg GRAPHIC 97999
5 GRAPHIC exhibit99-1x2x1.jpg GRAPHIC 72992
6 GRAPHIC exhibit99-2x1x1.jpg GRAPHIC 111582
7 GRAPHIC exhibit99-2x2x1.jpg GRAPHIC 70975
  Complete submission text file 0001062993-15-002149.txt   494608
Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 15787847
SIC: 2834 Pharmaceutical Preparations